SBIR Phase I: Electronically Actuated Low Power Microfluidic Pump

Award Information
Agency:
National Science Foundation
Branch
n/a
Amount:
$100,000.00
Award Year:
2007
Program:
SBIR
Phase:
Phase I
Contract:
0711986
Agency Tracking Number:
0711986
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Illuminaria, LLC
117 Devlen Road, Ste 1675, Groton, NY, 13073
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
145383514
Principal Investigator:
Scott Stelick
MEng
(607) 592-3778
sstelick@illuminariallc.com
Business Contact:
Scott Stelick
MEng
(607) 592-3778
sstelick@illuminariallc.com
Research Institution:
n/a
Abstract
This Small Business Innovation Research (SBIR) Phase I research project will develop a low-cost, low-power, and disposable microfluidic Electrolytic Hydraulic Pumps (EHPs). Many emerging diagnostic and clinical applications, such as point-of-care Polymerase Chain Reaction (PCR) pathogen analysis and ambulatory drug infusion, require battery-powered fluid pumping systems that are lightweight, low power, and extremely accurate. Unfortunately, current syringe and roller pumps are too heavy and power-hungry for many portable applications. This research will develop matchbox-sized EHPs that can pump volumes ranging from 0.1 ml to 5 ml. In addition, a programmable control system that integrates an ultrasonic transit-time flow measurement system will be developed. This combination will produce a prototype that can deliver up to 5ml volumes at 3microL/minute with a 0.1microL/minute accuracy. This technology would also permit development of high-accuracy ""cigarette-pack""-sized wearable drug infusion systems. Emerging point-of-care systems analyze suspected pathogens via a PCR reaction carried out on a microfluidic chip. DNA purification and PCR reactions in the system require precise fluid delivery to ensure a reliable and repeatable pathogen analysis. The EHP Pumping system would permit design of disposable cartridges containing the pump, pre-measured reagents, and connectors. Another potential market for the proposed pumping technology would be for emerging ""animal-on-a-chip"" cell culturing systems and drug toxicology studies.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government